FLUARIX QUADRIVALENT Rx
Generic Name and Formulations:
Quadrivalent inactivated "split virus" influenza vaccine (types A and B); contains a total of 60mcg hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; may contain trace amounts of hydrocortisone, gentamicin, others; preservative-free.
Indications for FLUARIX QUADRIVALENT:
Adults and Children:
<6mos: not established. Each dose is 0.5mL by IM inj once in the anterolateral thigh (6–11mos) or the deltoid (≥12mos). 6mos–8yrs (previously unvaccinated): 2 doses, give at least 4 weeks apart; (vaccinated in a previous season): 1 or 2 doses (depending on vaccination history as per annual ACIP recommendation); if 2 doses, give at least 4 weeks apart. ≥9yrs: 1 dose.
Allergy to egg protein. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Pregnancy. Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.
Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.
Single-dose prefilled Tip-Lok syringes (0.5mL)—10
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Bleeding Disorder Treatments: Hemophilia A
- Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
- Bleeding Disorder Treatments: von Willebrand Disease
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|